Broadening the drug discovery pipeline

Verseon’s unique computational platform is driving the identification and optimization of novel drug candidates for a broad range of indications. To download the full article, please sign in.

Like Comment
Page of
Go to the profile of Verseon


Verseon is a technology-based pharmaceutical company that employs its proprietary computational drug discovery platform to develop novel therapeutics for today’s challenging diseases. Verseon’s platform can consistently design novel drugs that are unlikely to be found using conventional methods. The Company is applying its platform to a growing drug pipeline and currently has three active drug programs in the areas of anticoagulation, diabetic macular edema, and solid tumor cancers.

No comments yet.